Daniel B. Soland, Director at ACADIA PHARMACEUTICALS INC (ACAD), bought 10,000 shares at $22.52 ($235K) on 2018-03-02, disclosed to the SEC on 2018-03-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.02 | 2,000 | $46K | 19.6% |
| 2 | $24.09 | 3,000 | $72K | 30.8% |
| 3 | $24.52 | 2,000 | $49K | 20.9% |
| 4 | $22.52 | 3,000 | $68K | 28.8% |
| Total | $23.49 avg | 10,000 | $235K | 100% |
| Filing → |
| IDRA | BUY | 2021-03-05 | $39K | — | Filing → |
| KALV | BUY | 2019-09-30 | $213K | — | Filing → |
| VPHM | SELL | 2012-03-06 | $990K | — | Filing → |